Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Prescient Therapeutics.
RELATED STOCKHEAD STORIES
News
Market highlights and 5 ASX small caps to watch on Friday
Health & Biotech
Blood cancer is becoming a big killer but there are only a handful of ASX stocks fighting it
Health & Biotech
Prescient Therapeutics chooses three cancer programs for its next-generation CAR T platform
Health & Biotech
Chimeric IPO: What ASX stockspert Bhavdip143 likes so much about the $35m CAR T play
Health & Biotech
How CAR T cancer treatment saved Laurie Adami’s life
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
How CAR-T uses the body’s own immune system to fight cancer
News
Last Orders: What you might have missed today on the ASX
Stockhead TV
ASX small caps leading the fight against cancer
Health & Biotech
Dr Boreham’s Crucible: Why Prescient now has ‘substance and sizzle’
Health & Biotech
Sophisticated and professional investors line up to give Prescient Therapeutics cash
Health & Biotech
Health Kick Podcast: Chemo’s diminishing role, the ‘personalised’ approach to cancer treatment and PTX’s CAR-T innovations
Health & Biotech
Prescient partners with global cancer heavyweight to develop new treatments
Health & Biotech
Prescient gears up for growth with $6.5m raise as the race to cure cancer heats up
Health & Biotech
Prescient, Antisense the only green shoots in a sea of red
News
ASX Small Cap Lunch Wrap: Who’s teaching an old dog new tricks today?
News
